Skip to main content
Clinical Trials/NCT03125512
NCT03125512
Completed
Not Applicable

Comparing a Convenient Positional Therapy Device to CPAP for Treatment of Positional Obstructive Sleep Apnea, A Crossover Randomized Controlled Trial

Changi General Hospital1 site in 1 country41 target enrollmentFebruary 27, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Apnea Syndromes
Sponsor
Changi General Hospital
Enrollment
41
Locations
1
Primary Endpoint
Epworth Sleepiness Scale ( ESS)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This is a crossover randomized controlled trial comparing a convenient positional therapy (PT) device to continuous positive airway pressure (CPAP) in the treatment of positional obstructive sleep apnea (OSA).

Detailed Description

This study aims to compare a convenient positional therapy (PT) device used for 8 weeks to continuous positive airway pressure (CPAP) used for 8 weeks in patients with positional obstructive sleep apnea (OSA) in a crossover randomized controlled trial.

Registry
clinicaltrials.gov
Start Date
February 27, 2017
End Date
December 30, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 21 years and above
  • Epworth sleepiness scale 10 to 16
  • No CPAP treatment or PT treatment for past 6 months
  • A diagnosis of positional OSA based on a full in-laboratory overnight polysomnography with
  • Total apnea/hypopnea index (AHI) \>10 /hour and non-supine AHI \< 10/hour
  • Supine AHI greater than or equal to two times the non-supine AHI
  • At least 15 minutes of supine and non-supine sleep

Exclusion Criteria

  • Epworth sleepiness scale ≥17
  • Commercial driving
  • Unable or unwilling to use both treatments (CPAP and PT)
  • Concurrent use of therapy for OSA such as mandibular advancement splints
  • Conditions that preclude the ability to lie in a non-supine position, for example a shoulder injury
  • Uncontrolled severe medical/psychiatric conditions such as severe chronic heart failure, malignancy.
  • Patients with pacemaker
  • Skin sensitivity around the neck and/or open wound around their neck

Outcomes

Primary Outcomes

Epworth Sleepiness Scale ( ESS)

Time Frame: 8 weeks after the beginning of each intervention

Difference in sleepiness ( PT minus CPAP) measured by the Epworth Sleepiness Scale ( ESS) after 8 weeks of device use

Secondary Outcomes

  • Functional Outcomes of Sleep Questionnaire ( FOSQ)(8 weeks after the beginning of each intervention)
  • Apnea-hypopnea Index ( AHI, events/hr)(8 weeks after the beginning of each intervention)
  • 36-Item Short Form Survey (SF-36)(8 weeks after the beginning of each intervention)
  • Patient preference(Upon study completion at week 17)
  • Patient adherence ( hours of device use per night)(8 weeks after the beginning of each intervention)
  • Pittsburgh Sleep Quality Index (PSQI)(8 weeks after the beginning of each intervention)
  • DASS21 questionnaire(8 weeks after the beginning of each intervention)
  • Oxygen desaturation index (3%) and lowest oxygen saturation ( %)(8 weeks after the beginning of each intervention)

Study Sites (1)

Loading locations...

Similar Trials